Company Description
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally.
It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products.
It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials.
The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications.
Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries.
Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.
International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1833 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 21,500 |
| CEO | Jon Erik Fyrwald |
Contact Details
Address: 521 W 57th St New York, New York 10019 United States | |
| Phone | (212) 765-5500 |
| Website | iff.com |
Stock Details
| Ticker Symbol | IFF |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000051253 |
| CUSIP Number | 459506101 |
| ISIN Number | US4595061015 |
| Employer ID | 13-1432060 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Glenn Robert Richter | Executive Vice President and Chief Financial and Business Transformation Officer |
| Dr. Jennifer Amy Johnson Ph.D. | Executive Vice President, General Counsel and Corporate Secretary |
| Simon Herriott | President of Health and Biosciences |
| Yuvraj Arora | Executive Vice President and President of Nourish |
| Jon Erik Fyrwald | Chief Executive Officer and Director |
| Ralf Finzel Ph.D. | Executive Vice President and Global Operations Officer |
| Beril Yildiz | Senior Vice President, Corporate Controller and Chief Accounting Officer |
| Michael DeVeau | Senior Vice President of Corporate Finance and Investor Relations |
| Vic Verma | Executive Vice President and Chief Information Officer |
| Deborah Borg | Executive Vice President and Chief Human Resources, Diversity, Inclusion and Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2024 | DEFR14A | Filing |
| Mar 21, 2024 | 8-K | Current Report |
| Mar 21, 2024 | ARS | Filing |
| Mar 21, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 21, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 19, 2024 | 8-K | Current Report |
| Mar 14, 2024 | 25-NSE | Filing |
| Mar 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2024 | 10-K | Annual Report |